<DOC>
	<DOCNO>NCT01014975</DOCNO>
	<brief_summary>This study test drug , Plasmin ( Human ) , patient stroke due clot middle cerebral artery ( MCA ) . Plasmin enzyme cause clot lysis cleaving clot component , fibrin . In study , Plasmin ( Human ) administer locally catheter clot within 9 hour stroke onset . Three dos Plasmin ( Human ) ( 20 mg , 40 mg , 80 mg ) test 3 different group patient . Patients monitor image affected artery functional testing .</brief_summary>
	<brief_title>A Safety Dose Finding Study Plasmin ( Human ) Administered Into Middle Cerebral Artery Stroke Patients</brief_title>
	<detailed_description>This Phase 1/2a , open-label , multi-center , sequential dose escalation , safety study Plasmin ( Human ) acute ischemic stroke cause middle cerebral artery occlusion document arteriography . Plasmin ( Human ) administer catheter thrombus within 9 hour stroke onset . Approximately sixty-one ( 61 ) patient enrol receive Plasmin ( Human ) . The objective study determine safety escalate dos Plasmin ( Human ) determine proportion patient treatment success , define partial full recanalization .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Fibrinolysin</mesh_term>
	<criteria>1 . 18 85 year age 2 . Male female 3 . New focal , potentially disable neurologic deficit clinically localize MCA distribution 4 . Intraarterial therapy Plasmin complete within 9 hour stroke onset 5 . A National Institutes Health Stroke Scale score ≥ 4 ≤ 25 1 . Intracranial procedure intracranial systemic bleeding within last year 2 . Intracranial neoplasm ( except meningioma ) , septic embolism , unsecured aneurysm 3 . Active bleed 4 . History stroke previous 6 week 5 . Uncontrolled hypertension 6 . Renal disease renal dialysis 7 . Treatment plasminogen activator within last 48 hr . 8 . Therapy Glycoprotein IIb/IIIa inhibitor 5 day prior study enrollment time study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>stroke</keyword>
	<keyword>plasmin</keyword>
	<keyword>thrombus</keyword>
	<keyword>ischemic</keyword>
	<keyword>middle cerebral artery</keyword>
	<keyword>thrombolysis</keyword>
	<keyword>intra-arterial</keyword>
	<keyword>fibrin</keyword>
</DOC>